These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9192201)

  • 41. The ICH S5(R2) guideline for the testing of medicinal agents.
    Wise LD
    Methods Mol Biol; 2013; 947():1-11. PubMed ID: 23138891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonclinical reproductive toxicity testing requirements for drugs, pesticides, and industrial chemicals in India and China.
    Rao KS; Dong J
    Methods Mol Biol; 2013; 947():13-30. PubMed ID: 23138892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A regulatory overview of alternatives to animal testing: United States, Europe, and Japan.
    Mayer FL; Whalen EA; Rheins LA
    J Toxicol Cutaneous Ocul Toxicol; 1994; 13(1):3-22. PubMed ID: 11659896
    [No Abstract]   [Full Text] [Related]  

  • 44. [Response of Pharmaceutical Companies to the Crisis of Post-Marketing Clinical Trials of Anti-Cancer Agents -- Results of Questionnaires to Pharmaceutical Companies].
    Nakajima T
    Gan To Kagaku Ryoho; 2016 Apr; 43(4):486-9. PubMed ID: 27220801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A retrospective analysis of the added value of the rat two-generation reproductive toxicity study versus the rat subchronic toxicity study.
    Janer G; Hakkert BC; Piersma AH; Vermeire T; Slob W
    Reprod Toxicol; 2007 Jul; 24(1):103-13. PubMed ID: 17600672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Container-content compatibility studies: a pharmaceutical team's integrated approach.
    Laschi A; Sehnal N; Alarcon A; Barcelo B; Caire-Maurisier F; Delaire M; Feuilloley M; Genot S; Lacaze C; Pisarik L; Smati C
    PDA J Pharm Sci Technol; 2009; 63(4):285-93. PubMed ID: 20088243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulatory forum opinion piece*: supporting the need for international harmonization of safety assessments for food flavoring substances.
    Konishi Y; Hayashi SM; Fukushima S
    Toxicol Pathol; 2014 Aug; 42(6):949-53. PubMed ID: 23881932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Threshold of toxicological concern (TTC) for developmental and reproductive toxicity of anticancer compounds.
    Stanard B; Dolan DG; Hanneman W; Legare M; Bercu JP
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):602-9. PubMed ID: 26025210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The further evolution of biotech.
    Nagle T; Berg C; Nassr R; Pang K
    Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of globalization under the ICH guidelines on the conduct of reproductive toxicity studies--report on current status in Japan, Europe and the U.S. by questionnaire survey.
    Mineshima H; Endo Y; Ogasawara H; Nishigaki K; Numa T; Hirano F; Matsuzawa T
    J Toxicol Sci; 2004 Aug; 29(3):201-15. PubMed ID: 15467270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toxicity assessment strategies, data requirements, and risk assessment approaches to derive health based guidance values for non-relevant metabolites of plant protection products.
    Dekant W; Melching-Kollmuss S; Kalberlah F
    Regul Toxicol Pharmacol; 2010 Mar; 56(2):135-42. PubMed ID: 19883711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proposal for international guidelines for reproductive and developmental toxicity testing for pharmaceuticals.
    Lumley CE
    Adverse Drug React Toxicol Rev; 1991; 10(3):143-53. PubMed ID: 1747441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns.
    Golub MS; Macintosh MS; Baumrind N
    J Toxicol Environ Health B Crit Rev; 1998; 1(3):199-241. PubMed ID: 9644328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reproductive and developmental toxicity studies of toluene. II. Effects of inhalation exposure on fertility in rats.
    Ono A; Sekita K; Ogawa Y; Hirose A; Suzuki S; Saito M; Naito K; Kaneko T; Furuya T; Kawashima K; Yasuhara K; Matsumoto K; Tanaka S; Inoue T; Kurokawa Y
    J Environ Pathol Toxicol Oncol; 1996; 15(1):9-20. PubMed ID: 9037260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implications of recommendations from the International Conference on Harmonization (ICH) for the safety evaluation of new medicines involving animal studies for the pharmaceutical industry.
    Scales MD
    Adverse Drug React Toxicol Rev; 1992; 11(1):5-12. PubMed ID: 1606283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Women's opinions about routine HIV testing during pregnancy: implications for the opt-out approach.
    Podhurst LS; Storm DS; Dolgonos S
    AIDS Patient Care STDS; 2009 May; 23(5):331-7. PubMed ID: 19405811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of cephacetrile on reproduction cycle.
    Esposti G; Esposti D; Guerino G; Bichisao E; Fraschini F
    Arzneimittelforschung; 1986 Mar; 36(3):484-6. PubMed ID: 3707668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The value and benefits of the International Conference on Harmonisation to drug regulatory authorities: advancing harmonization for better public health.
    Molzon JA; Giaquinto A; Lindstrom L; Tominaga T; Ward M; Doerr P; Hunt L; Rago L
    Clin Pharmacol Ther; 2011 Apr; 89(4):503-12. PubMed ID: 21326288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guidelines for developmental toxicity testing of chemicals in Japan.
    Tanimura T
    Neurobehav Toxicol Teratol; 1985; 7(6):647-52. PubMed ID: 3835459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Economic advantage of pharmacogenomics - clinical trials with genetic information.
    Ohashi W; Mizushima H; Tanaka H
    Stud Health Technol Inform; 2008; 136():585-90. PubMed ID: 18487794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.